These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11496642)

  • 1. [Clinical picture of arthritis caused by psoriasis].
    van Romunde LK
    Acta Rhumatol; 1979; 3(3):207-11. PubMed ID: 11496642
    [No Abstract]   [Full Text] [Related]  

  • 2. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
    Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
    Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis.
    Chandran V; Schentag CT; Gladman DD
    Arthritis Rheum; 2007 Dec; 57(8):1560-3. PubMed ID: 18050230
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnetic resonance imaging of nail unit in psoriatic arthritis.
    Soscia E; Scarpa R; Cimmino MA; Atteno M; Peluso R; Sirignano C; Costa L; Iervolino S; Caso F; Del Puente A; Salvatore M; Soricelli A
    J Rheumatol Suppl; 2009 Aug; 83():42-5. PubMed ID: 19661539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis.
    Shibata S; Tada Y; Komine M; Hattori N; Osame S; Kanda N; Watanabe S; Saeki H; Tamaki K
    J Dermatol Sci; 2009 Jan; 53(1):34-9. PubMed ID: 18752933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal fingernails.
    Usatine RP
    J Fam Pract; 2003 Feb; 52(2):137-9. PubMed ID: 12585991
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to cyclic citrullinated peptides in psoriatic arthritis.
    Bogliolo L; Alpini C; Caporali R; Scirè CA; Moratti R; Montecucco C
    J Rheumatol; 2005 Mar; 32(3):511-5. PubMed ID: 15742445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis.
    Pasquetti P; Morozzi G; Galeazzi M
    Rheumatology (Oxford); 2009 Mar; 48(3):315-6. PubMed ID: 19109316
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide in psoriasis and psoriatic arthritis: a preliminary study.
    Thami GP; Garg G
    Arch Dermatol; 2004 Oct; 140(10):1288-9. PubMed ID: 15492204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intrafamilial examinations in psoriatic arthritis].
    Theiss B; Schnyder UW; Böni A; Wagenhäuser F
    Z Rheumaforsch; 1969; 28(11):403-24. PubMed ID: 5375051
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis.
    Gisondi P; Girolomoni G; Sampogna F; Tabolli S; Abeni D
    Eur J Dermatol; 2005; 15(4):279-83. PubMed ID: 16048759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriatic arthritis sine psoriasis.
    Olivieri I; Padula A; D'Angelo S; Cutro MS
    J Rheumatol Suppl; 2009 Aug; 83():28-9. PubMed ID: 19661535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The psoriatic continuum: a new concept].
    Boulinguez S; Jullien D
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H5-7. PubMed ID: 21703462
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrence risk for psoriasis and psoriatic arthritis within sibships.
    Myers A; Kay LJ; Lynch SA; Walker DJ
    Rheumatology (Oxford); 2005 Jun; 44(6):773-6. PubMed ID: 15757963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey.
    Radtke MA; Reich K; Blome C; Rustenbach S; Augustin M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):683-91. PubMed ID: 19309433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail and distal interphalangeal joint in psoriatic arthritis.
    Scarpa R; Soscia E; Peluso R; Atteno M; Manguso F; Del Puente A; Spanò A; Sirignano C; Oriente A; Di Minno MN; Iervolino S; Salvatore M
    J Rheumatol; 2006 Jul; 33(7):1315-9. PubMed ID: 16758507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and epidemiological evaluation of psoriasis: clinical variants and articular manifestations.
    Aslanian FM; Lisboa FF; Iwamoto A; Carneiro SC
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):141-2. PubMed ID: 15649217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.